Published by Josh White on 31st March 2023
(Sharecast News) - Pharmaceuticals developer Hutchmed China announced the completion of its rolling submission of a new drug application (NDA) to the US Food and Drug Administration (FDA) for its oral inhibitor 'fruquintinib'.
URL: http://www.digitallook.com/dl/news/story/33408694/...